TIL cell therapy in HIV positive patient with metastatic melanoma: case report - Top-Institutions - MDSpire

TIL cell therapy in HIV positive patient with metastatic melanoma: case report

  • By

  • Brian Whetsell

  • Juan Alban

  • Adam Y. Lin

  • Jeffrey D. Wayne

  • Sunandana Chandra

  • May 20, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    National Cancer Institute
    National Cancer Institute

    Bethesda, Maryland

    Key Differentiators

    • Oncology
    • Cancer Research

  • #2

    Moffitt Cancer Center
    Moffitt Cancer Center

    Tampa, Florida

    Key Differentiators

    • Oncology
    • Immunotherapy

  • #3

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Hematology

  • #4

    City of Hope
    City of Hope

    Duarte, California

    Key Differentiators

    • Oncology
    • Transplantation

  • #5

    Institut Gustave Roussy
    Institut Gustave Roussy

    Villejuif, France

    Key Differentiators

    • Oncology
    • Medical Oncology

Original Source(s)

TIL cell therapy in HIV positive patient with metastatic melanoma: case report

  • by Brian Whetsell, Juan Alban, Adam Y. Lin, Jeffrey D. Wayne, Sunandana Chandra

  • May 20, 2026

Related Content

Errors in the Table 2

  • May 1, 2026

Microbial Profiles in the Gut and Their Association with Immunotherapy Efficacy in Non-Small Cell Lung Cancer and Melanoma: A Comprehensive Review and Meta-Analysis

Impact of thrombosis on disease progression, cancer and mortality in patients with essential thrombocythemia and polycythemia vera